Clinical Trial

Amplitude Vascular Systems (AVS) Lithotripsy POWER PAD 2 Trial

Study acronym: POWER PAD 2
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 18, 2026 (before its estimated March 2026 completion). Its status may not reflect the trial's current state.
Summary
POWER PAD 2 is a prospective, single-arm, multicenter, non-randomized clinical study designed to demonstrate the safety and effectiveness of the Amplitude Vascular Systems (AVS) Pulse Intravascular Lithotripsy™ (Pulse IVL™) System for treatment of calcified (moderate to severe), stenotic, superficial femoral and popliteal arteries in patients with peripheral arterial disease.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2024-06-10; most recent amendment 2026-02-16.
Status change: Recruiting → Active, Not Recruiting 2026-02-16
Status change: Not Yet Recruiting → Recruiting 2024-09-20
Trial Details
NCT Number NCT06457685
Lead Sponsor Amplitude Vascular Systems, Inc.
Conditions Peripheral Arterial Disease (PAD)
Enrollment 115 participants
Start Date 2024-09-05
Primary Completion 2026-03 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2026-02-18